Clinical Trials for Syneos Health

A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

Study to Detect Dendritic Cell Recruitment in Human Retina

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers

Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

ETNA-MS Device Validation Study

Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

RegoNivo vs Standard of Care Chemotherapy in AGOC

TH1902 in Patients With Advanced Solid Tumors

"Phase III, Efficacy and Safety of Kamada-AAT for Inhalation"

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.